Latest Breaking News On - Avenue therapeutics company profile - Page 1 : comparemela.com

Avenue Therapeutics, Inc (NASDAQ:ATXI) Sees Large Growth in Short Interest

Avenue Therapeutics, Inc. (NASDAQ:ATXI – Get Free Report) was the recipient of a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 1,110,000 shares, an increase of 378.9% from the December 31st total of 231,800 shares. Based on an average daily volume of 5,910,000 shares, […]

United statesRenaissance technologiesCitadel advisorsMaxim groupVirtu financialAvenue therapeutics incAvenue therapeutics company profileAvenue therapeuticsGet free reportSigma investmentsState street corpAvenue therapeutics dailyNasdaq atxi

Avenue Therapeutics, Inc (NASDAQ:ATXI) Sees Large Growth in Short Interest

Avenue Therapeutics, Inc (NASDAQ:ATXI) Sees Large Growth in Short Interest
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United statesAvenue therapeutics incAvenue therapeutics company profileVirtu financialMaxim groupCitadel advisorsSabby managementAvenue therapeuticsGet free reportSigma investmentsStreet corpAvenue therapeutics daily

Short Interest in Avenue Therapeutics, Inc (NASDAQ:ATXI) Increases By 39 0%

Avenue Therapeutics, Inc. (NASDAQ:ATXI – Get Free Report) was the target of a large growth in short interest during the month of October. As of October 31st, there was short interest totalling 513,700 shares, a growth of 39.0% from the October 15th total of 369,700 shares. Based on an average trading volume of 156,200 shares, […]

United statesGeode capital managementCitadel advisorsAvenue therapeutics company profileVirtu financialSecurities exchange commissionAvenue therapeutics incFortress biotech incAvenue therapeuticsGet free reportTherapeutics trading downFortress biotechExchange commissionDirector lindsaySigma investmentsStreet corp

Avenue Therapeutics, Inc (NASDAQ:ATXI) Sees Large Growth in Short Interest

Avenue Therapeutics, Inc (NASDAQ:ATXI) Sees Large Growth in Short Interest
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United statesGeode capital managementAvenue therapeutics incVirtu financialAvenue therapeutics company profileRenaissance technologiesFortress biotech incAvenue therapeuticsGet free reportFortress biotechDirector lindsayStreet corpCapital managementTwo sigma investmentsAvenue therapeutics daily

Avenue Therapeutics, Inc (NASDAQ:ATXI) Director Buys $251,046 00 in Stock

Avenue Therapeutics, Inc. (NASDAQ:ATXI – Get Free Report) Director Lindsay A. Md Rosenwald purchased 348,675 shares of the company’s stock in a transaction dated Friday, September 8th. The shares were bought at an average cost of $0.72 per share, for a total transaction of $251,046.00. Following the acquisition, the director now owns 354,318 shares in […]

United statesRenaissance technologiesGeode capital managementVirtu financialAvenue therapeutics company profileAvenue therapeutics incAvenue therapeuticsGet free reportDirector lindsayStreet corpCapital managementTwo sigma investmentsAvenue therapeutics dailyNasdaq atxiInsider tradingNsider trades